Pliant Therapeutics Receives $45,000,000 Series A Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=78c83c75-e0ac-4f26-916f-4b4151df9b51 - Date
2/19/2016 - Company Name
Pliant Therapeutics - Mailing Address
700 Saginaw Drive Redwood City, CA 94063 USA - Company Description
Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. - Website
http://www.pliantrx.com - Transaction Type
Venture Equity - Transaction Amount
$45,000,000 - Transaction Round
Series A - Proceeds Purposes
Pliant’s product engine has the potential to address the needs of many patients by targeting fibrosis in a variety of organs and conditions, including the lungs (IPF), liver (NASH and cirrhosis), kidney (renal fibrosis), skin (scleroderma), heart (cardiac fibrosis) and the gastrointestinal tract (Crohn’s disease). - M&A Terms
- Venture Investor
Third Rock Ventures - Venture Investor
Undisclosed
